» Articles » PMID: 7473831

Recruiting Minorities into Clinical Trials: Toward a Participant-friendly System

Overview
Specialty Oncology
Date 1995 Dec 6
PMID 7473831
Citations 176
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this review is to describe the state of the art in recruiting participants for clinical trials designed to test new methods of treatment or disease prevention. The ultimate objective of this review is to provide a summary of key issues in recruiting diverse populations into clinical trials, particularly ethnic and racial minorities. An overview of general issues related to clinical trial participation is followed by a detailed discussion of specific issues that must be addressed by investigators as they recruit minority populations for clinical trial. To date, the majority of clinical trials have included a limited segment of the U.S. population: middle-class, married white males. These trials have faced many problems in their efforts to recruit participants, including barriers to physician participation, barriers to subject participation, barriers to planning and implementing effective recruitment strategies, and costs of the recruitment phase of clinical trials. Following this general introduction is a discussion of the definition of diverse populations. The first step investigators must take as they prepare to recruit study participants is to develop a relevant definition of the subject populations. A detailed review of investigators' experiences in recruiting minorities into clinical trials is presented, including barriers to minority recruitment, barriers inherent in study design, researcher bias, barriers to minority physician participation, as well as strategies for minority recruitment, modifications of study design, and cost issues. Formal evaluation of recruitment strategies has been limited. Most investigators present descriptive reports of their experience in recruiting diverse populations into clinical trials. Research into the issues presented and rigorous testing of specific strategies is needed. A series of steps that are essential to effective clinical trials recruitment of diverse populations is presented.

Citing Articles

Reporting and representation of participant race and ethnicity in phase III clinical trials for solid tumors.

Wang T, Villanueva D, Banerjee A, Gifkins D Future Sci OA. 2025; 11(1):2458415.

PMID: 39885684 PMC: 11792851. DOI: 10.1080/20565623.2025.2458415.


Supporting diversity in clinical trials: the equitable breakthroughs in medicine site maturity model.

Harris T, Nunez-Smith M, Suttiratana S, Fretz S, Leonard S, Linnander E Trials. 2024; 25(1):764.

PMID: 39543751 PMC: 11566401. DOI: 10.1186/s13063-024-08594-9.


Bridging the Gap: Culturally Responsive Strategies for NIH Trial Recruitment.

Ross L, Eberlein S, Khalil C, Choi S, McKelvey K, Spiegel B J Racial Ethn Health Disparities. 2024; .

PMID: 39470977 DOI: 10.1007/s40615-024-02166-y.


Feasibility and Acceptability Study of a Culturally Adapted Web-Based Intervention to Reduce Suicidal Ideation for Syrian Asylum Seekers and Refugees in the United Kingdom: Protocol for a Mixed Methods Study.

Beuthin O, Shahid S, Yu L, Bhui K JMIR Res Protoc. 2024; 13:e56957.

PMID: 39222345 PMC: 11406105. DOI: 10.2196/56957.


The Inclusion of Underrepresented Populations in Cardiovascular Genetics and Epidemiology.

Chappell E, Arbour L, Laksman Z J Cardiovasc Dev Dis. 2024; 11(2).

PMID: 38392270 PMC: 10888590. DOI: 10.3390/jcdd11020056.